Filtered By:
Management: Insurers
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 70 results found since Jan 2013.
A Year in Review: FDA 2015 New Drug Approvals
The approval of first-of-a-kind drugs rose last year to forty-one, resulting in the highest level of newly approved U.S. drugs in nineteen years. The total number of new drugs approved last year was even higher at sixty-nine. The rising figures reflect an industry-wide desire to research and develop drugs for rare and hard-to-treat diseases.
The newly approved drugs serve to advance medical care and the health of patients suffering from many ailments, including various forms of cancer, heart failure, and cystic fibrosis. Additionally, more than 40% of the new therapies were approved for treatment of rare or "orphan" dise...
Source: Policy and Medicine - January 13, 2016 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Telehealth under alternative payment models
The post below originally ran on Milliman, Inc. on November 23.
Telehealth, as a modality of delivering healthcare services, is growing in terms of acceptance and adoption. There are a few key drivers for this dynamic: (1) consumer demand for convenient access to care; (2) availability of lower-cost telehealth technologies; (3) clinician comfort and willingness to provide certain services remotely; and (4) evolving payment models that seek to incentivize value and better population health.
Evolving payment models reflect the need to mitigate perverse incentives for the unnecessary healthcare utilization, waste, and ineffic...
Source: Disruptive Women in Health Care - November 25, 2015 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Innovation Technology Source Type: blogs
TRIAL BY ERROR: The Troubling Case of the PACE Chronic Fatigue Syndrome Study
By David Tuller, DrPH
David Tuller is academic coordinator of the concurrent masters degree program in public health and journalism at the University of California, Berkeley.
A few years ago, Dr. Racaniello let me hijack this space for a long piece about the CDC’s persistent incompetence in its efforts to address the devastating illness the agency itself had misnamed “chronic fatigue syndrome.” Now I’m back with an even longer piece about the U.K’s controversial and highly influential PACE trial. The $8 million study, funded by British government agencies, purportedly proved that patients could “recover” fr...
Source: virology blog - October 21, 2015 Category: Virology Authors: Vincent Racaniello Tags: Information adaptive pacing therapy CFS chronic fatigue syndrome clinical trial cognitive behavior therapy Dave Tuller exercise graded exercise therapy mecfs myalgic encephalomyelitis outcome PACE trial recovery Source Type: blogs
Getting To The ACO Tipping Point: What Else Might Be Needed?
Editor’s note: This post was authored by Madeleine Phipps-Taylor on behalf of the West Coast Harkness Policy Forum.
There are currently over 740 commercial, Medicare, and Medicaid accountable care organization (ACO) contracts operating in the U.S. This new health care contracting mechanism has grown rapidly over the last three years, and yet the future of the model is by no means secured. Across the U.S. there have been rumblings about the model’s financial attractiveness, complexity, and impact.
At what seems to be a moment of reflection—as the new Centers for Medicare and Medicaid Services (CMS) rules f...
Source: Health Affairs Blog - June 3, 2015 Category: Health Management Authors: Madeleine Phipps-Taylor Tags: Following the ACA Health Professionals Medicaid and CHIP Medicare Organization and Delivery Payment Policy Quality ACOs clinical culture CMS International Pioneer ACO West Coast Policy Forum Source Type: blogs
Beyond Law Enforcement: The FTC’s Role In Promoting Health Care Competition And Innovation
By now, the Federal Trade Commission’s (FTC) law enforcement efforts in the health care area are well known. We have successfully challenged several hospital and physician practice mergers in the last few years. We also continue to pursue anticompetitive pharmaceutical patent settlements, following a victory at the Supreme Court in the Actavis case. Speaking of the Court, it is currently reviewing a case we brought against the North Carolina Board of Dental Examiners, alleging that its members conspired to exclude non-dentists from providing teeth whitening services in North Carolina.
Perhaps less publicized are the FTC...
Source: Health Affairs Blog - January 26, 2015 Category: Health Management Authors: Maureen Ohlhausen Tags: All Categories Competition Connected Health Consumers Health Care Costs Health Law Innovation Policy States Technology Workforce Source Type: blogs
Healthcare Update Satellite — 09-15-2014
This study should be required reading in every emergency medicine residency in this country. In fact, the concepts in the studies should be tested on the emergency medicine board exams.
Now if the study only compared the type of a patient’s insurance with the likelihood of emergency department recidivism.
How else can the media try to tarnish this guy’s reputation? The doctor who oversaw Joan Rivers’ fatal endoscopy was once *sued* 10 years ago. Gasp.
The former patient’s attorneys are really trying to create their 15 minutes of fame. They alleged that 10 years ago the patient received no informed ...
Source: WhiteCoat's Call Room - September 15, 2014 Category: Emergency Medicine Authors: WhiteCoat Tags: Healthcare Update Source Type: blogs
Sovaldi - a "Revolution" in Clinical Care, or in Marketing and Public Relations?
DiscussionWashington Post/ Kaiser Health NewsOn May 12, 2014, in an article on the dilemma the drug's US price of $1000/ pill presents to Medicare, Richard Knox wrote this about a patient with the infection:Previous drug treatments didn't clear the virus from Bianco's system. But it's almost certain that potent new drugs for hep-C could cure him. In other words, the article asserted that Sovaldi and similar drugs cure nearly everyone with hepatitis C, even those not cured by previous treatment. ReutersOn May 20, 2014, in an article about how US health insurers are balking at the price of Sovaldi, was this statement b...
Source: Health Care Renewal - May 28, 2014 Category: Health Management Tags: evidence-based medicine Gilead health care prices manipulating clinical research Sovaldi You heard it here first Source Type: blogs
Flu shots 101 and why YOU need one
I think everyone should get a flu shot, and if you haven’t had one yet now is the time. The more people are vaccinated, the fewer chances everybody has of contracting the flu and passing it along to somebody who has a compromised immune system. If you know and love a young adult cancer patient, get a flu shot. If you don’t know one of us, do it for your elderly grandma, your infant nephew, or just because you care about the well being of a stranger. Flu shots are not just about protecting yourself, they are about helping to protect your community.
Lots of myths about flu shots prevent people from gettin...
Source: Everything Changes - November 12, 2013 Category: Cancer Authors: Kairol Rosenthal Tags: Uncategorized Source Type: blogs
Are We Waiting For Godot?
Ten reasons I feel pessimism about our current healthcare environment (in brief):
Process vs Product
Computers are just machines. I repeat, they are just tools. Health information technology is a shell which houses knowledge and human ability. It is nothing more . Electronic medical records may either streamline our thought processes or make them more cluttered. They will not, however, lead to better or more perfect care. They haven't yet, and they won't in the future. And they are prone to be adulterated by commercial intentions. Looking for an answer to our complex healthcare p...
Source: In My Humble Opinion - November 11, 2013 Category: Family Physicians Authors: Jordan Grumet Source Type: blogs
Should You Keep Your Mental Illness a Secret at Work?
It’s bad enough that most health insurance companies will gladly discriminate against you for having a pre-existing mental illness, such as bipolar disorder or attention deficit hyperactivity disorder (ADHD).
But what about other people, like your coworkers? Will they still treat you the same if they knew you had a mental illness?
Depending on where you worked, you might find the answer surprising, even in the year 2013.
For those of who’ve been working in mental health advocacy for years, it seems unimaginable that there are companies or workplaces where the sharing of your mental health concern would be det...
Source: World of Psychology - August 25, 2013 Category: Psychiatrists and Psychologists Authors: John M. Grohol, Psy.D. Tags: General Industrial and Workplace Mental Health and Wellness Policy and Advocacy Psychology Adhd Affordable Care Attention Deficit Hyperactivity Disorder Care Act Career Condition Clauses Coworkers Health Concern Health Insurance Source Type: blogs
Transcript of President Obama’s Remarks at the National Conference on Mental Health
This is an edited transcript of President Obama’s remarks to the participants of the National Conference on Mental Health, held in the White House on June 3, 2013. Our coverage of the National Conference on Mental Health will continue here tomorrow with a summary of the conference.
President Obama: Thank you so much. Everybody please have a seat. Thank you so much. Welcome to the White House. Thank you Janelle for that introduction and sharing your story and making such a difference through your organization. We’re really proud to have you here. I want to thank Secretary Sebelius, Secretary Arnie Dunca...
Source: World of Psychology - June 4, 2013 Category: Psychiatrists and Psychologists Authors: John M. Grohol, Psy.D. Tags: General Mental Health and Wellness Policy and Advocacy Psychology Advocates Arnie Duncan Critical Goal Decades Eric Shinseki Eve Faith Leaders Fellow Americans June 3 Leadership Main Goal Members Of Congress Mental Health C Source Type: blogs
Return of the “???” monster
The bane of many a Dexcom 7 Plus user was the infamous triple question mark icon:???Officially, it meant that the receiver couldn’t understand the signals coming off of the sensor. Basically the receiver was asking the CGM sensor, “What the f. are you saying?” Of course users would also start off by asking the receiver, “What the f.?” and end (hours later) by screaming at the receiver, “WHAT THE F.?!!!!!”Naturally, the dreaded triple-Q icon showed up at the worst possible times: when you were going to bed with a ton of insulin on board, when you had the flu, were getting married or divorced, going to prom, or...
Source: LifeAfterDx--The Guardian Chronicles - May 15, 2013 Category: Diabetes Authors: Wil Source Type: blogs
EHR Debates and The Growth of mHealth – Around Healthcare Scene
With the dissatisfaction that many have felt from EMR, providers and patients alike, outside healthcare companies are coming up with new ideas on how to help. Healthpons, a healthcare version of Groupon, recently launched and aims to help people find affordable care, and allow providers to market themselves. Is this “cash for care” model a trickle down effect of EMR Dissatisfaction?
Among the debates related to EHRs, one of the biggest is about purging data. On one side, people believe that all data from a person’s life in order to give the best care possible. Another camp believes that keeping EHR data...
Source: EMR and HIPAA - April 8, 2013 Category: Technology Consultants Authors: Katie Tags: EHR Electronic Health Record Electronic Medical Record EMR EMR Technology Healthcare HealthCare IT Hospitals Meaningful Use Around Healthcare Scene Health IT mHealth Source Type: blogs
Pharmalot… Pharmalittle… The Weekend Nears
And so, another working week is drawing to a close. Actually, we are rolling in the sidewalks momentarily, since this is an official day off here at the Pharmalot corporate campus. The schoolhouses are closed and we promised the short people we would spend some time with them. So we have arranged a few items for you and then will be on our way. As for you, we hope you do something fun, interesting or worthwhile – or all of the above – this weekend. After all, life is short. Might as well enjoy. And while you do, please be safe. See you soon…
Feds Probe J&J Over Hip Implant Marketing (Associated Press...
Source: Pharmalot - February 22, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Active Pharmaceutical Ingredients API Breast Cancer Dan Vasella Diet Pills Elan Flu Genentech Influenza JJ Johnson & Johnson Novartis Obesity Patient Adherence Roche Vaccines Vivus Source Type: blogs
If The Drug Is Cheap, It Must Be Good?
Yes, you read that correctly. In an era when more high-priced biologics are being introduced all the time, consumers believe that a truly vital medicine is less expensive. Why? Consumers believe prices are based on need, not profit, and assume the risk of getting a serious illness is higher when the drug is cheaper, according to a new study. As a result, they are also more likely to seek treatment.
This might seem counterintuitive, to some, if only because there is an assumption that an item is likely to have more value if it is priced higher. Not everyone believes this, of course, but the implication can be that a higher-...
Source: Pharmalot - February 6, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Flu Prescription Drug Pricing Source Type: blogs
